Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Immune system ‘could aggravate BRSV’
Scientists say large numbers of neutrophils contribute to some of the short term clinical signs associated with BRSV.
Decreasing neutrophil response could improve clinical signs - study  

Immune cells designed to clear infections could worsen respiratory disease caused by bovine respiratory syncytial virus (BRSV), according to new research.

The team of international scientists behind the study are the first to simultaneously examine hundreds of proteins that are involved in the response of calves to BRSV, which infects the lungs of cattle.

Findings published in PLOS ONE suggest there is a link between the numbers of immune cells, or neutrophils, clinical signs of disease, lung tissue damage and the amount of virus in the lungs of infected calves.

It is thought that neutrophils aid the clearance of of BRSV - and the closely related human respiratory syncytial virus (HRSV) - by removing infected cells. When they appear in excessive numbers, however, they appear to have the opposite effect, releasing harmful substances that destroy the lung and block the airways.

Scientists say large numbers of neutrophils contribute to some of the short term clinical signs associated with BRSV, such as breathing problems.

An exaggerated neutrophil response can also result in longer-term effects, the study suggests. This is down to their ability to remodel lung tissue, which increases the time it takes for clinical signs to clear, even after the virus has been eliminated. In severe and early human RSV infections, it is thought that over-stimulation of neutrophils could increase the likelihood of asthma.

Dr Geraldine Taylor, honorary fellow at Pirbright Institute, said: “Our findings suggest treatments that decrease the response of neutrophils could improve clinical signs both in the short and long term.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.